APA (7th ed.) Citation

A, A., JA, B., DJ, F., RE, R. R., S, A., R, W., . . . RC, P. (2026). Variability in Clinical Performance of the FDA-Cleared Lumipulse P-Tau217/β-Amyloid 1-42 Plasma Ratio. JAMA neurology. https://doi.org/10.1001/jamaneurol.2026.1565

Chicago Style (17th ed.) Citation

A, Algeciras-Schimnich, et al. "Variability in Clinical Performance of the FDA-Cleared Lumipulse P-Tau217/β-Amyloid 1-42 Plasma Ratio." JAMA Neurology 2026. https://doi.org/10.1001/jamaneurol.2026.1565.

MLA (9th ed.) Citation

A, Algeciras-Schimnich, et al. "Variability in Clinical Performance of the FDA-Cleared Lumipulse P-Tau217/β-Amyloid 1-42 Plasma Ratio." JAMA Neurology, 2026, https://doi.org/10.1001/jamaneurol.2026.1565.